Your browser doesn't support javascript.
loading
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC).
Chen, Helen X; Song, Minkyung; Maecker, Holden T; Gnjatic, Sacha; Patton, David; Lee, J Jack; Adam, Stacey J; Moravec, Radim; Liu, Xiaole Shirley; Cerami, Ethan; Lindsay, James; Tang, Ming; Hodi, F Stephen; Wu, Catherine J; Wistuba, Ignacio I; Al-Atrash, Gheath; Bernatchez, Chantale; Bendall, Sean C; Hewitt, Stephen M; Sharon, Elad; Streicher, Howard; Enos, Rebecca A; Bowman, Melissa D; Tatard-Leitman, Valerie M; Sanchez-Espiridion, Beatriz; Ranasinghe, Srinika; Pichavant, Mina; Del Valle, Diane M; Yu, Joyce; Janssens, Sylvie; Peterson-Klaus, Jenny; Rowe, Cathy; Bongers, Gerold; Jenq, Robert R; Chang, Chia-Chi; Abrams, Jeffrey S; Mooney, Margaret; Doroshow, James H; Harris, Lyndsay N; Thurin, Magdalena.
  • Chen HX; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland. thurinm@mail.nih.gov helen.chen@nih.gov.
  • Song M; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland.
  • Maecker HT; The Human Immune Monitoring Center (HIMC), Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California.
  • Gnjatic S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Patton D; Center for Biomedical Informatics and Information Technology, NCI, Bethesda, Maryland.
  • Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Adam SJ; Foundation for the National Institutes of Health, North Bethesda, Maryland.
  • Moravec R; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland.
  • Liu XS; Kelly Services, Rockville, Maryland.
  • Cerami E; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lindsay J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tang M; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hodi FS; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wu CJ; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wistuba II; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Al-Atrash G; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Bernatchez C; Harvard Medical School, Boston, Massachusetts.
  • Bendall SC; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Hewitt SM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sharon E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Streicher H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Enos RA; Department of Pathology, School of Medicine, Stanford University, Stanford, California.
  • Bowman MD; Laboratory of Pathology, Center for Cancer Research, NCI, Bethesda, Maryland.
  • Tatard-Leitman VM; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland.
  • Sanchez-Espiridion B; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland.
  • Ranasinghe S; The Emmes Company, LLC, Rockville, Maryland.
  • Pichavant M; The Emmes Company, LLC, Rockville, Maryland.
  • Del Valle DM; The Emmes Company, LLC, Rockville, Maryland.
  • Yu J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Janssens S; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Peterson-Klaus J; The Human Immune Monitoring Center (HIMC), Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California.
  • Rowe C; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Bongers G; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Jenq RR; The Emmes Company, LLC, Rockville, Maryland.
  • Chang CC; Foundation for the National Institutes of Health, North Bethesda, Maryland.
  • Abrams JS; Center for Biomedical Informatics and Information Technology, NCI, Bethesda, Maryland.
  • Mooney M; Essex Management, Rockville, Maryland.
  • Doroshow JH; Microbiome Translational Center, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Harris LN; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Thurin M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 27(18): 5038-5048, 2021 09 15.
Article en En | MEDLINE | ID: mdl-33419780
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Monitorización Inmunológica / Biomarcadores de Tumor / Inmunoterapia / Neoplasias Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Monitorización Inmunológica / Biomarcadores de Tumor / Inmunoterapia / Neoplasias Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article